Emily Johnson is Senior Counsel, IP Litigation at Amgen, one of the world’s most innovative biotechnology companies. Emily oversees Amgen’s U.S. and foreign patent litigations and post-grant proceedings before the Patent Trial and Appeal Board and she provides counsel regarding Amgen’s intellectual property strategies. Before joining Amgen, she represented clients in private practice, litigating nearly 100 intellectual property disputes in both judicial and administrative tribunals. Emily had the privilege of clerking for the Honorable Arthur Gajarsa at the Federal Circuit. Emily co-chairs the PTAB Committee of the Federal Circuit Bar Association and chairs the U.S. Post-Grant Patent Office Practice Committee of Intellectual Property Owners Association.